In cancer, the ALK gene can undergo several types of alterations, including gene fusions, mutations, and amplifications. One common alteration is the EML4-ALK fusion, often seen in non-small cell lung cancer (NSCLC). In this fusion, the ALK gene combines with another gene (EML4), leading to the production of an abnormal protein that can promote uncontrolled cell growth.
